Glimepiride: all 77 studies that test it
Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.
- Hypertension Treatment in Nigeria: Hypertension Diabetes Integration Study- Formative Aim 3RecruitingNCT07589387Not applicable
- Efficacy Evaluation of Glimepiride in Patients With Type 2 Diabetes Mellitus and Chronic Heart Failure With Reduced Ejection Fraction.Not yet recruitingNCT07288749Phase 3
- Interaction of Bexagliflozin With Metformin, Glimepiride and SitagliptinCompletedNCT02956044Phase 1Results posted
- Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes SubjectsCompletedNCT02769481Phase 3Results posted
- Efficacy and Safety of Dapagliflozin and Dapagliflozin Plus Saxagliptin in Combination With Metformin in Type 2 Diabetes Patients Compared With SulphonylureaCompletedNCT02471404Phase 4Results posted
- A 52-week International, Multicenter Trial With a Long -Term Extension to Evaluate Saxagliptin With Dapagliflozin in Combination With Metformin Compared to Glimepiride in Combination With Metformin in Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin AloneCompletedNCT02419612Phase 3Results posted
- Glycemic Excursions in Type 2 Diabetic Patients With Vildagliptin and Metformin Versus Vildagliptin and GlimepirideCompletedNCT02007278Phase 4Results posted
- A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 DiabetesCompletedNCT01794143Phase 3Results posted
- Effects of Glimepiride on Recovery From Hypoglycemia in Participants With Type 2 Diabetes Mellitus (MK-0000-253)CompletedNCT01614769Phase 1Results posted
- Long-term Safety Study of Alogliptin Used in Combination With Sulfonylurea or Metformin in Participants With Type 2 Diabetes in JapanCompletedNCT01318135Phase 2/3Results posted
- Efficacy and Safety of Alogliptin Used in Combination With Sulfonylurea in Participants With Type 2 Diabetes in JapanCompletedNCT01318083Phase 2/3Results posted
- Study of the Durability of Glycemic Control With NateglinideCompletedNCT00858013Phase 4Results posted
- Glimepiride 4 mg Tablets Under Non-Fasting ConditionsCompletedNCT00835172Phase 1Results posted
- Glimepiride 4 mg Tablets Under Fasting ConditionsCompletedNCT00834340Phase 1Results posted
- Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00614120Phase 3Results posted
- 24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 DiabetesCompletedNCT00318656Phase 4Results posted
- Avandia™ + Amaryl™ or Avandamet™ Compared With Metformin (AVALANCHE™ Study)CompletedNCT00131664Phase 3Results posted
- Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT)CompletedNCT00032487Phase 3Results posted
- Bioequivalence Study of 3 mg Glimepiride Tablet in Indonesia Healthy SubjectsCompletedNCT05468879Not applicable
- The Effect of Glimepiride Compared With Sitagliptin as an add-on Therapy to Metformin in Severe Insulin Deficiency DiabetesStatus unknownNCT05386186Phase 4
- Oral Combination of Glimepiride/Vildagliptin/Metformin in Patients With T2D and Dual Treatment FailureCompletedNCT04841096Phase 3
- Fenofibrate Versus Curcumin in Type 2 Diabetic PatientsCompletedNCT04528212Phase 4
- Glimepiride, Alogliptin and Alogliptin+Pioglitazone CombinationStatus unknownNCT04470310Phase 4
- Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic AgentsStatus unknownNCT04287387Phase 4
- Dosage Reduction and Acute Glycemic Complications in People With Type 2 Diabetes Who Fast During RamadanCompletedNCT04237493Phase 4
- A Study to Evaluate the Renal Protective Effect (Urine Albumin-to-Creatinine Ratio (UACR)), Efficacy and Safety of Ipragliflozin in Type 2 Diabetes Mellitus Patients With AlbuminuriaTerminatedNCT03118713Phase 4
- The Effect of GIP and GLP-1 on Insulin and Glucagon Secretion in Patients With HNF1A-diabetes Treated With or Without SulphonylureaCompletedNCT03081676Not applicable
- Comparison of Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and Glimepiride as add-on MetforminTerminatedNCT03060980Phase 3
- Teneligliptin-Glimepiride DDI StudyCompletedNCT03009513Phase 1
- SGLT2 Inhibitor Versus Sulfonylurea on Type 2 Diabetes With NAFLDCompletedNCT02649465Phase 4
- Metabolic and Cardiovascular Effects of Dipeptidyl Peptidase-4 (DPP-4) or Sodium-glucose Co-transporter Type 2 (SGLT2) InhibitorsStatus unknownNCT02528019Phase 4
- Dynamic Responsiveness of Insulin Secretory Parameters To Sitagliptin and Glimeperide Administration in Type 2 DMStatus unknownNCT02443922Not applicable
- Efficacy and Safety of Saxagliptin VS. Glimepiride in Chinese T2DM Patients Controlled Inadequately With MetforminCompletedNCT02280486Phase 4
- Relative Bioavailability of BI 10773 and Glimepiride in Healthy Male VolunteersCompletedNCT02172261Phase 1
- Glycemic Durability After Metformin FailureStatus unknownNCT02142309Phase 4
- Renal Effects of DPP-4 Inhibitor Linagliptin in Type 2 DiabetesCompletedNCT02106104Phase 4
- Efficacy/Safety Study of Glimepiride to Type 2 Diabetes Patients Based on Metformin And Basal Insulin TreatmentCompletedNCT02026310Not applicable
- Effects of Gemigliptin Versus Sitagliptin or Glimepiride With Metformin on Glucose Variability(MAGE, Glucose SD) Patients With Type 2 DM(STABLE Study)CompletedNCT01890629Phase 4
- Effects of Vildagliptine and Glimepiride on Glucose VariabilityCompletedNCT01812122Phase 4
- Pharmacokinetic Drug Interaction Study Between Gemigliptin and Glimepiride in Healthy Male SubjectsCompletedNCT01768455Phase 1
- Bioequivalence Study of 4 mg Glimepiride TabletCompletedNCT01677247Not applicable
- Study of Comparing the Different Effect of DPP-4 Inhibitors and Sulfonylurea by Using "Biphase-Hyperglycemic Clamp"Status unknownNCT01660386Phase 4
- Study of Metabolic and Haemodynamic Effects of Metformin and Glimepiride in Patients With Type 2 Diabetes MellitusCompletedNCT01509001Phase 4
- TAK-875 Glimepiride Drug-Interaction StudyCompletedNCT01496443Phase 1
- A Comparison of Atorvastatin and Glimepiride Fixed Dose Combination and Atorvastatin and Glimepiride Loose Combination in the Treatment of Patients With Type 2 Diabetes MellitusCompletedNCT01495013Phase 3
- Efficacy and Safety Comparison of Metformin/Glimepiride Combination Versus Each Compound Alone in New Diagnosed Type 2 Diabetes PatientsCompletedNCT01459809Phase 3
- Evaluation of Fixed Dose Combination of Glimepiride and Metformin in Chinese Type 2 Diabetes Patients Inadequately Controlled With MetforminCompletedNCT01457911Phase 3
- Compare the Compliance of Patients Treated With Once-daily (od) or Twice-daily (Bid) Glimepiride and Metformin Fixed Combination TherapyCompletedNCT01444248Phase 4
- Endothelial Disfunction Treatment With Glimepiride/Metformin Combination (Glimetal) in Type 2 Diabetes PatientsCompletedNCT01429818Phase 4
- Liraglutide and Heart Failure in Type 2 DiabetesCompletedNCT01425580Phase 2
- Drug-drug Interaction Study With ASP1941 and GlimepirideCompletedNCT01302158Phase 1
- ADIponectin and Asymmetric Dimethylarginine (ADMA) Level in Type-2 Diabetes Patients After 12 Weeks of Treatment With GlimepiRide And Metformin Fixed Dose CombinationCompletedNCT01204580Phase 4
- Initiation and Titration of AmarylCompletedNCT01144728Phase 4
- Bioequivalence Study of Dr.Reddys Laboratories Limited, Glimepiride 1 mg Tablets in Healthy Subjects Under Fed ConditionCompletedNCT01053689Phase 1
- Bioequivalence Study of Dr.Reddy's Laboratories Limited, Glimepiride Tablets 1 mg Under Fasting ConditionCompletedNCT01052909Phase 1
- Superiority of Glimepiride Over Sitagliptin in Naive Type 2 Diabetes PatientsCompletedNCT00957060Phase 4
- Efficacy and Safety of Glimepiride as Oral Anti-Diabetic (OAD) Initiation Mono-therapy in Chinese Type 2 Diabetes Mellitus (T2DM)CompletedNCT00908921Phase 4
- Pharmacokinetic Drug Interaction Study of Dapagliflozin and Glimepiride or Sitagliptin in Healthy SubjectsCompletedNCT00842556Phase 1
- Insulin Glargine Combination Therapies in Type II DiabeticsCompletedNCT00783744Phase 3
- Bioequivalence Study of Glimepiride 1mg Tablets Under Fed ConditionsCompletedNCT00776620Not applicable
- Bioequivalence Study of Glimepiride 1mg Tablets Under Fasting ConditionsCompletedNCT00776490Not applicable
- Efficacy of Pioglitazone and Glimepiride Combination Therapy in Treating Subjects With Type 2 Diabetes Mellitus.CompletedNCT00770952Phase 3
- How Improvement in Control of Diabetes Influences the Production of a Hormone Produced in the Gut Which Improves the Release and Action of Insulin.CompletedNCT00747383Not applicable
- Risk Reduction in Coronary Heart DiseaseCompletedNCT00679237Not applicable
- Food Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mgCompletedNCT00650533Phase 1
- Fasting Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mgCompletedNCT00648362Phase 1
- Insulin Glargine Benefits in Japanese Pts Outside of Japan (US or Brazil)CompletedNCT00642915Phase 4
- Continuous Glucose Monitoring System (CGMS) in Type 2 Diabetic Patients Inadequately Controlled by Metformine Monotherapy; Analyze of Glycemic Profile Before and After Association of GlimepirideCompletedNCT00633425Phase 4
- Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 DiabetesCompletedNCT00619697Phase 4
- Glimepiride Induced Insulin Secretion Will be Inhibited by HypoglycemiaCompletedNCT00608179Not applicable
- Metabolic Effects of Pioglitazone in Type II Diabetic Patients Previously Treated With InsulinCompletedNCT00576784Phase 4
- Pharmacokinetic Drug Interaction Study With Dapagliflozin and Glimepiride in Healthy SubjectsCompletedNCT00562250Phase 1
- Phase III Study for Glimepiride + Metformin Hydrochloride (Amaryl M) Slow Release (SR)CompletedNCT00437554Phase 3
- Glimepiride vs Metformin as Monotherapy in Pediatric Subjects With Type 2 Diabetes MellitusCompletedNCT00353691Phase 3
- Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00331851Phase 3
- Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00318422Phase 3
- Evaluate the Role of Adding Amaryl to Non-Insulin Dependent Diabetes Mellitus Patients Unresponsive to Maximum Dose Metformin & ThiazolidinedioneCompletedNCT00044447Phase 3